Evidence map›Paper›PMID 28077070›Full record

ArticleBMC bioinformatics2017

SCOPA and META-SCOPA: software for the analysis and aggregation of genome-wide association studies of multiple correlated phenotypes.

Reedik Mägi, Yury V Suleimanov, Geraldine M Clarke, Marika Kaakinen, Krista Fischer, Inga Prokopenko, Andrew P Morris

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Diabetology & metabolic syndrome · 2018
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Reedik MägiEstonian Genome Center, University of Tartu, Tartu, Estonia.
Yury V SuleimanovComputation-based Science and Technology Research Center, Cyprus Institute, Nicosia, Cyprus.
Geraldine M ClarkeWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Marika KaakinenGenomics of Common Disease, Imperial College, London, UK.
Krista FischerEstonian Genome Center, University of Tartu, Tartu, Estonia.
Inga ProkopenkoGenomics of Common Disease, Imperial College, London, UK.
Andrew P MorrisEstonian Genome Center, University of Tartu, Tartu, Estonia. apmorris@liverpool.ac.uk.
Centre for Human Genetics · GBGenomics England · GBUniversity of Tartu · EEMassachusetts Institute of Technology · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundGenome-wide association studies (GWAS) of single nucleotide polymorphisms (SNPs) have been successful in identifying loci contributing genetic effects to a wide range of complex human diseases and quantitative traits. The traditional approach to GWAS analysis is to consider each phenotype separately, despite the fact that many diseases and quantitative traits are correlated with each other, and often measured in the same sample of individuals. Multivariate analyses of correlated phenotypes have been demonstrated, by simulation, to increase power to detect association with SNPs, and thus may enable improved detection of novel loci contributing to diseases and quantitative traits.

resultsWe have developed the SCOPA software to enable GWAS analysis of multiple correlated phenotypes. The software implements "reverse regression" methodology, which treats the genotype of an individual at a SNP as the outcome and the phenotypes as predictors in a general linear model. SCOPA can be applied to quantitative traits and categorical phenotypes, and can accommodate imputed genotypes under a dosage model. The accompanying META-SCOPA software enables meta-analysis of association summary statistics from SCOPA across GWAS. Application of SCOPA to two GWAS of high-and low-density lipoprotein cholesterol, triglycerides and body mass index, and subsequent meta-analysis with META-SCOPA, highlighted stronger association signals than univariate phenotype analysis at established lipid and obesity loci. The META-SCOPA meta-analysis also revealed a novel signal of association at genome-wide significance for triglycerides mapping to GPC5 (lead SNP rs71427535, p = 1.1x10

conclusionsThe SCOPA and META-SCOPA software enable discovery and dissection of multiple phenotype association signals through implementation of a powerful reverse regression approach.

Indexed as

Body Mass IndexCholesterol, HDLCholesterol, LDLGenome-Wide Association StudyHumansModels, TheoreticalObesityPhenotypeSoftwareTriglyceridesCholesterol, HDLCholesterol, LDLTriglyceridesCorrelationGenome-wide association studyMeta-analysisMultiple phenotypesMultivariate analysisReverse regression

Identifiers

PMID28077070
PMCPMC5225593
OpenAlexW2570881184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.